CLINICAL_TRIALS
trial_result
· 2023-02-10
Clinical Trial Update: Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia [Phase 2]
Summary
A Phase 2 clinical trial of evinacumab (REGN1500) in participants with persistent hypercholesterolemia has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2023-02-10